FDA approves treatment for refractory multiple myeloma despite health risks
The drug, rimegepant, is awaiting FDA approval and may offer advantages over currently available migraine medications (Credit: Pixabay)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X